TY - JOUR
T1 - Motor neuron disease in three asymptomatic pVal50Met TTR gene carriers
AU - Santos Silva, Cláudia
AU - Oliveira Santos, Miguel
AU - Gromicho, Marta
AU - Pronto-Laborinho, Ana
AU - Conceição, Isabel
AU - de Carvalho, Mamede
N1 - Publisher Copyright:
© 2022 World Federation of Neurology on behalf of the Research Group on Motor Neuron Diseases.
PY - 2022
Y1 - 2022
N2 - We describe three unrelated patients with sporadic motor neuron disease (MND) and hereditary amyloid transthyretin (ATTRv) amyloidosis family history, who were asymptomatic carriers of the pVal50Met mutation of transthyretin (TTR) gene. Patients 1 and 2 were a 43-year-old man with a spinal-onset of ALS and a 37-year-old woman with a bulbar-onset of ALS, who died due to respiratory complications five and two years after disease onset, respectively. Patient 3 is a 52-year-old woman, with a two-year history of a probable primary lateral sclerosis, and a frontotemporal dysfunction. Imaging, cerebrospinal fluid (CSF) and nerve conduction and small fiber tests were normal in all. Genetic testing for ALS was negative in the two patients tested. Previous studies in MND patients have identified reduced TTR levels in CSF and neuronal gene overexpression, suggesting a neuroprotective role of TTR. The association of MND in patients with TTR gene mutations has not yet been described.
AB - We describe three unrelated patients with sporadic motor neuron disease (MND) and hereditary amyloid transthyretin (ATTRv) amyloidosis family history, who were asymptomatic carriers of the pVal50Met mutation of transthyretin (TTR) gene. Patients 1 and 2 were a 43-year-old man with a spinal-onset of ALS and a 37-year-old woman with a bulbar-onset of ALS, who died due to respiratory complications five and two years after disease onset, respectively. Patient 3 is a 52-year-old woman, with a two-year history of a probable primary lateral sclerosis, and a frontotemporal dysfunction. Imaging, cerebrospinal fluid (CSF) and nerve conduction and small fiber tests were normal in all. Genetic testing for ALS was negative in the two patients tested. Previous studies in MND patients have identified reduced TTR levels in CSF and neuronal gene overexpression, suggesting a neuroprotective role of TTR. The association of MND in patients with TTR gene mutations has not yet been described.
KW - Amyotrophic lateral sclerosis
KW - TTR gene
KW - motor neuron disease
KW - primary lateral sclerosis
KW - transthyretin
UR - http://www.scopus.com/inward/record.url?scp=85125132686&partnerID=8YFLogxK
U2 - 10.1080/21678421.2022.2029899
DO - 10.1080/21678421.2022.2029899
M3 - Article
C2 - 35142241
AN - SCOPUS:85125132686
SN - 2167-8421
VL - 23
SP - 627
EP - 629
JO - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
JF - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
IS - 7-8
ER -